Searched for
GSK INDIA SHARES
Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...
Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
GSK India Q2 Results: Net profit grows 11% YoY to Rs 216 croreOur Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held l...
GSK, Horlicks to sell HUL shares worth Rs 26,000 crore todayJP Morgan, Morgan Stanley and HSBC are the book runners to the trade.
GSK preparing to start Rs 28,000 crore stake sale in HULET Now, quoting agencies, said GSK PLc is likely to start the discussion of its stake in the next few days.
NCLT clears GSK-HUL merger, paves way for GSK Plc’s exit through huge block dealOfficials aware of the developments say Morgan Stanley is readying the share sale process.
GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
Unilever used HUL buyback gains to secure GSK health dealUnilever bought back HUL shares at Rs 600 apiece 5 years ago which has appreciated to Rs 1,700 now. Unilever diluted 5.3% HUL stake in GSK ...
Taxmen begin scrutiny of Unilever-GSK dealTax officials could also raise the issue that GST of 12% is applicable on the overseas transaction.
GSK Consumer jumps over 1% on merger with HULThe scrip was 1.57 per cent up at Rs 7,383.85 at around 02.27 pm.
GSK exploring merger, share swap with potential buyersGSK had conducted an internal analysis involving tax experts in Europe and India and a handful of external tax consultants in UK to discove...
Glaxo considering all options against CCI orderSlapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals today said it would review the or...
GSK raises India unit stake to 75% via open offerWe are very pleased with the outcome of this transaction, which further increases our exposure to a strategically important market," GSK Ch...
GSK Pharma rallies 20% as parent initiates open offerThe parent of GlaxoSmithKline Pharmaceuticals Ltd plans to increase its stake from 50.7 per cent to up to 75 per cent at an offer price of ...
Parent offer talk spurs GSK PharmaIt may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...
GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
- DRL, GSK ink pact to develop, market generics
Dr Reddy’s Laboratories (DRL) has partnered with GlaxoSmithKline (GSK) to develop and market generics and formulations in emerging markets ...